Stocks
Humana Financial Statements (HUM) |
||||||||||
| Humanasmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 20.02.2020 | 18.02.2021 | 17.02.2022 | 16.02.2023 | 15.02.2024 | 24.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 64 888 | 77 155 | 83 064 | 92 870 | 106 440 | 109 243 | |||
| Operating Income, bln rub | 3 470 | 4 674 | 3 418 | 3 969 | 4 013 | 3 570 | ||||
| EBITDA, bln rub | ? | 4 045 | 5 290 | 4 131 | 4 814 | 4 597 | 4 028 | |||
| Net profit, bln rub | ? | 2 707 | 3 367 | 2 933 | 2 806 | 2 489 | 1 991 | |||
| OCF, bln rub | ? | 5 284 | 5 639 | 2 262 | 4 587 | 3 981 | -2 283 | |||
| CAPEX, bln rub | ? | 736.0 | 964.0 | 1 316 | 1 120 | 1 004 | 958.0 | |||
| FCF, bln rub | ? | 4 548 | 4 675 | 946.0 | 3 467 | 2 977 | -3 241 | |||
| Dividend payout, bln rub | 291.0 | 323.0 | 354.0 | 392.0 | 431.0 | 440.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 10.7% | 9.59% | 12.1% | 14.0% | 17.3% | 22.1% | ||||
| OPEX, bln rub | 61 418 | 72 481 | 79 646 | 89 070 | 13 908 | 57 804 | ||||
| Cost of production, bln rub | 7 381 | 10 052 | 10 121 | 12 671 | 13 188 | 13 251 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 242.0 | 283.0 | 326.0 | 401.0 | 493.0 | 539.0 | ||||
| Assets, bln rub | 29 074 | 34 969 | 44 343 | 43 055 | 46 892 | 50 091 | ||||
| Net Assets, bln rub | ? | 12 037 | 13 728 | 16 080 | 15 311 | 16 262 | 16 130 | |||
| Debt, bln rub | 5 891 | 6 980 | 12 820 | 11 424 | 12 269 | 13 212 | ||||
| Cash, bln rub | 15 026 | 17 227 | 16 586 | 18 942 | 21 320 | 22 607 | ||||
| Net debt, bln rub | -9 135 | -10 247 | -3 766 | -7 518 | -9 051 | -9 395 | ||||
| Ordinary share price, rub | 366.5 | 410.3 | 463.9 | 512.2 | 457.8 | 481.1 | ||||
| Number of ordinary shares, mln | 134.1 | 132.2 | 128.7 | 126.4 | 123.9 | 121.0 | ||||
| Market cap, bln rub | 49 134 | 54 237 | 59 693 | 64 751 | 56 707 | 58 201 | ||||
| EV, bln rub | ? | 39 999 | 43 990 | 55 927 | 57 233 | 47 656 | 48 806 | |||
| Book value, bln rub | 7 932 | 8 952 | 2 349 | 4 404 | 5 019 | 4 888 | ||||
| EPS, rub | ? | 20.2 | 25.5 | 22.8 | 22.2 | 20.1 | 16.5 | |||
| FCF/share, rub | 33.9 | 35.4 | 7.35 | 27.4 | 24.0 | -26.8 | ||||
| BV/share, rub | 59.2 | 67.7 | 18.3 | 34.8 | 40.5 | 40.4 | ||||
| EBITDA margin, % | ? | 6.23% | 6.86% | 4.97% | 5.18% | 4.32% | 3.69% | |||
| Net margin, % | ? | 4.17% | 4.36% | 3.53% | 3.02% | 2.34% | 1.82% | |||
| FCF yield, % | ? | 9.26% | 8.62% | 1.58% | 5.35% | 5.25% | -5.57% | |||
| ROE, % | ? | 22.5% | 24.5% | 18.2% | 18.3% | 15.3% | 12.3% | |||
| ROA, % | ? | 9.31% | 9.63% | 6.61% | 6.52% | 5.31% | 3.97% | |||
| P/E | ? | 18.2 | 16.1 | 20.4 | 23.1 | 22.8 | 29.2 | |||
| P/FCF | 10.8 | 11.6 | 63.1 | 18.7 | 19.0 | -18.0 | ||||
| P/S | ? | 0.76 | 0.70 | 0.72 | 0.70 | 0.53 | 0.53 | |||
| P/BV | ? | 6.19 | 6.06 | 25.4 | 14.7 | 11.3 | 11.9 | |||
| EV/EBITDA | ? | 9.89 | 8.32 | 13.5 | 11.9 | 10.4 | 12.1 | |||
| Debt/EBITDA | -2.26 | -1.94 | -0.91 | -1.56 | -1.97 | -2.33 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 1.13% | 1.25% | 1.58% | 1.21% | 0.94% | 0.88% | ||||
| Humana shareholders | ||||||||||
